The WHO estimates the average medication adherence rate is 50% in developed nations, though the U.S. trails other countries in reported adherence on Medisafe.…


Tough luck, pharma. Trump may cut taxes and regulations, but he still backs Medicare price negotiation

NICE fulfills Pfizer exec's prophecy with Ibrance snub

Pfizer weighs $2B-plus portfolio sale that could drum up dealmaking funds: Bloomberg

Pharma CEOs, eager for tax breaks and regulatory help, make nice with Trump

Mallinckrodt highlights patient success stories to spruce up its image—and the industry’s

Pfizer's Prevnar misses big on Q4 sales, dragging vaccines unit down with it

Questions swirl around Pfizer's I-O efforts, dealmaking future amid Q4 EPS miss

AZ nabs 6 more months of Symbicort exclusivity—and the sales that come with it

The top 10 drug launches of 2017

GSK debuts new fireball character for Prevacid OTC heartburn drug